mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |